Literature DB >> 25483741

Histopathological heterogeneity of in-stent restenosis in four coronary endarterectomy specimens.

Akira Takashima1, Michio Shimabukuro2, Minoru Tabata3, Daiju Fukuda4, Etsuko Uematsu1, Hatsue Ishibashi-Ueda5, Shuichiro Takanashi3, Masataka Sata1.   

Abstract

Here, we histopathologically compare four patients undergoing coronary artery bypass with coronary endarterectomy and onlay patch grafting for in-stent restenosis (ISR) after the implantation of a bare-metal stent (BMS), sirolimus-eluting stent (SES), or paclitaxel-eluting stent (PES) in an everolimus-eluting stent (EES). Heterogeneity of ISR was noted histopathologically. In ISR for BMS, restenosis is likely caused by so-called neoatherosclerosis that occurred which altered the healing process of BMS implantation. Two ISR cases for SES showed a histopathological heterogeneity: one showed nodular calcified thrombus around stent strut protruding into the lumen, and the other showed concentric neointima composed of CD68-positive foam cell proliferation. In the ISR lesion for PES in EES, infiltrations with foam cells macrophages, particularly numerous eosinophilic cell infiltrations, suggest a peristent strut hypersensitivity reaction. We found a remarkable histopathological heterogeneity of ISR. The study using coronary endarterectomy specimens can give us pivotal information about the histopathological heterogeneity of ISR.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coronary artery bypass; Coronary endarterectomy; In-stent restenosis; Percutaneous coronary intervention

Mesh:

Year:  2014        PMID: 25483741     DOI: 10.1016/j.carpath.2014.11.002

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  2 in total

1.  TLR3 and TLR4 as potential clinical biomarkers for in-stent restenosis in drug-eluting stents patients.

Authors:  Shao Liang; Ma Aiqun; Li Jiwu; Zhang Ping
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 2.  Hypersensitivity and in-stent restenosis in coronary stent materials.

Authors:  Wansong Hu; Jun Jiang
Journal:  Front Bioeng Biotechnol       Date:  2022-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.